Contract molder and manufacturer Phillips-Medisize Corp. (Hudson, WI) has announced the acquisition of Medicom Innovation Partner (Struer, Denmark), a provider of device strategy, product design and development services with particular focus on personal, connected drug-delivery devices. Terms of the transaction were not disclosed.
Through this acquisition, Phillips-Medisize says that it will bolster its leading position in drug-delivery device solutions. Together, the combined company will have more than 500 engineers across facilities in Hudson, WI; Mountain View, CA; Hillegom, Netherlands; Struer, Denmark; Cambridge, UK; and Suzhou, China. The addition of Medicom’s capabilities expands Phillips-Medisize’s end-to-end injectable and inhalation device solutions for biopharma customers, including early device strategy, human factors engineering, product development, clinical production, full-scale production and integrated supply chain management.
“This transaction is consistent with our strategic focus on serving the rapidly growing diabetes, biologics, specialty pharmaceutical and personalized oncology markets that need these products and reinforces our leading position in drug-delivery device solutions,” said Matt Jennings, Chairman, CEO and President of Phillips-Medisize. “Medicom’s impressive solutions, 25 years of expertise and 100+ state-of-the-art technology accelerators, coupled with Phillips-Medisize’s scale in design to manufacturing of high- to low-volume production drug-delivery devices, will provide customers with end-to-end integrated service solutions, resulting in increased speed to market,” said Jennings.
“We are confident that customers of both companies will benefit from an enhanced offering of end-to-end integrated service solutions across a global network while continuing to receive the same best-in-class service that they have come to expect,” said Morten Nielsen, CEO of Medicom. “Importantly, our companies are culturally aligned and we share the same deep-rooted passion for innovation which improves our customers’ competitiveness.”
Medicom Innovation Partner was established as a technology venture of Bang & Olufsen A/S in 1989 and the company has been active in the drug-device space for more than 25 years.
Medicom will continue to be led by Nielsen and Medicom’s existing management team. Nielsen will report to Bill Welch, Phillips-Medisize’s Chief Technology Officer and global leader of preproduction services.